Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green JA Carr, D Franke, JR Caram, CF Perkinson, M Saif, V Askoxylakis, ... Proceedings of the National Academy of Sciences 115 (17), 4465-4470, 2018 | 611 | 2018 |
Solid stress and elastic energy as measures of tumour mechanopathology HT Nia, H Liu, G Seano, M Datta, D Jones, N Rahbari, J Incio, ... Nature biomedical engineering 1 (1), 0004, 2016 | 385 | 2016 |
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival J Kloepper, L Riedemann, Z Amoozgar, G Seano, K Susek, V Yu, ... Proceedings of the National Academy of Sciences 113 (16), 4476-4481, 2016 | 339 | 2016 |
Long-term survival of cancer patients compared to heart failure and stroke: a systematic review V Askoxylakis, C Thieke, ST Pleger, P Most, J Tanner, K Lindel, HA Katus, ... BMC cancer 10, 1-8, 2010 | 313 | 2010 |
Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood–tumor barrier disruption CD Arvanitis, V Askoxylakis, Y Guo, M Datta, J Kloepper, GB Ferraro, ... Proceedings of the National Academy of Sciences 115 (37), E8717-E8726, 2018 | 206 | 2018 |
Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium G Seano, HT Nia, KE Emblem, M Datta, J Ren, S Krishnan, J Kloepper, ... Nature biomedical engineering 3 (3), 230-245, 2019 | 171 | 2019 |
Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials NN Rahbari, H Elbers, V Askoxylakis, E Motschall, U Bork, MW Büchler, ... Annals of surgical oncology 20, 4169-4182, 2013 | 155 | 2013 |
Emerging strategies for treating brain metastases from breast cancer DP Kodack, V Askoxylakis, GB Ferraro, D Fukumura, RK Jain Cancer cell 27 (2), 163-175, 2015 | 153 | 2015 |
Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy EI Ager, SV Kozin, ND Kirkpatrick, G Seano, DP Kodack, V Askoxylakis, ... Journal of the National Cancer Institute 107 (4), djv017, 2015 | 126 | 2015 |
A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy S Zitzmann, W Mier, A Schad, R Kinscherf, V Askoxylakis, S Krämer, ... Clinical Cancer Research 11 (1), 139-146, 2005 | 109 | 2005 |
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation DP Kodack, V Askoxylakis, GB Ferraro, Q Sheng, M Badeaux, S Goel, ... Science translational medicine 9 (391), eaal4682, 2017 | 108 | 2017 |
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525)±anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies P Schöffski, DSW Tan, M Martín, M Ochoa-de-Olza, J Sarantopoulos, ... Journal for immunotherapy of cancer 10 (2), 2022 | 106 | 2022 |
Preclinical evaluation of the breast cancer cell-binding peptide, p160 V Askoxylakis, S Zitzmann, W Mier, K Graham, S Krämer, F Von Wegner, ... Clinical cancer research 11 (18), 6705-6712, 2005 | 91 | 2005 |
Preclinical efficacy of ado-trastuzumab emtansine in the brain microenvironment V Askoxylakis, GB Ferraro, DP Kodack, M Badeaux, RC Shankaraiah, ... Journal of the National Cancer Institute 108 (2), djv313, 2016 | 82 | 2016 |
Intensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer F Roeder, NH Nicolay, T Nguyen, L Saleh-Ebrahimi, V Askoxylakis, ... Radiation Oncology 9, 1-9, 2014 | 80 | 2014 |
Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis V Askoxylakis, P Hegenbarth, C Timke, L Saleh-Ebrahimi, J Debus, ... Radiation oncology 11, 1-9, 2016 | 59 | 2016 |
Dual inhibition of IGF-1R and ErbB3 enhances the activity of gemcitabine and nab-paclitaxel in preclinical models of pancreatic cancer AJ Camblin, EA Pace, S Adams, MD Curley, V Rimkunas, L Nie, G Tan, ... Clinical Cancer Research 24 (12), 2873-2885, 2018 | 56 | 2018 |
Molecular imaging of tumor metabolism and apoptosis U Haberkorn, A Markert, W Mier, V Askoxylakis, A Altmann Oncogene 30 (40), 4141-4151, 2011 | 53 | 2011 |
Multidisciplinary pain management based on a computerized clinical decision support system in cancer pain patients T Bertsche, V Askoxylakis, G Habl, F Laidig, J Kaltschmidt, SPW Schmitt, ... Pain® 147 (1-3), 20-28, 2009 | 52 | 2009 |
Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models WS Kamoun, DB Kirpotin, ZR Huang, SK Tipparaju, CO Noble, ME Hayes, ... Nature Biomedical Engineering 3 (4), 264-280, 2019 | 49 | 2019 |